These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 288583)

  • 61. B and T lymphocyte activation by murine leukemia virus infection.
    Bendinelli M; Friedman H
    Adv Exp Med Biol; 1979; 121B():91-7. PubMed ID: 317564
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Studies of cloned Friend erythroleukemia tumor cells. Modulation of the tumor-specific cytologic T lymphocyte response by infectious Friend virus production in vitro.
    Plata F; Goodenow MM; Lilly F
    J Exp Med; 1980 Mar; 151(3):726-42. PubMed ID: 6965703
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Emergence of tumorigenic cells during the course of Friend virus leukemias.
    Wendling F; Moreau-Gachelin F; Tambourin P
    Proc Natl Acad Sci U S A; 1981 Jun; 78(6):3614-8. PubMed ID: 6943562
    [TBL] [Abstract][Full Text] [Related]  

  • 64. The spleen in Friend leukemia. II. Nonleukemic nature of spleen stroma.
    Levy SB; Rubenstein CB; Tavassoli M
    J Natl Cancer Inst; 1976 Jun; 56(6):1189-95. PubMed ID: 1069139
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Immunotherapy of murine leukemia. V. Protection against Friend leukemia virus-induced immune complex glomerulonephritis by passive serum therapy.
    Sanfilippo F; Genovesi EV; Collins JJ
    J Natl Cancer Inst; 1981 Sep; 67(3):703-17. PubMed ID: 6456369
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Immunosuppression induced in vitro by cell-free extracts of Friend leukemia virusinfected splenocytes.
    Specter S; Patel C; Friedman H
    J Natl Cancer Inst; 1976 Jan; 56(1):143-7. PubMed ID: 768498
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Cell membrane maturation of Friend erythroleukemic cells and tocopherol-dependent erythropoietin effect: a scanning electron microscopic study.
    Malik Z; Langzam Y
    Cell Differ; 1982 May; 11(3):161-7. PubMed ID: 6956453
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Immunosuppression by Friend leukemia virus is H-2 restricted by alloreactive T lymphocytes.
    Kumar V; Bennett M
    Proc Natl Acad Sci U S A; 1979 May; 76(5):2415-9. PubMed ID: 313055
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Modulation of natural killer (nk) cell activity during FLV-P virus infection of mice.
    Migliorati G; Jezzi T; Frati L; Bonmassar E; Rossi GB; Garaci E; Riccardi C
    Int J Cancer; 1983 Jan; 31(1):81-90. PubMed ID: 6219962
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Suppression of natural killer cell activity by Friend murine leukemia virus.
    Moody DJ; Specter S; Bendinelli M; Friedman H
    J Natl Cancer Inst; 1984 Jun; 72(6):1349-56. PubMed ID: 6202923
    [TBL] [Abstract][Full Text] [Related]  

  • 71. In vitro growth inhibition of murine leukemia cells by antibody specific for the major envelope glycoprotein (gp71) of Friend leukemia virus.
    Genovesi EV; Collins JJ
    J Cell Physiol; 1983 Nov; 117(2):215-29. PubMed ID: 6630299
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Studies on the role of the host immune response in recovery from Friend virus leukemia. II. Cell-mediated immunity.
    Chesebro B; Wehrly K
    J Exp Med; 1976 Jan; 143(1):85-99. PubMed ID: 1081583
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Effects of Friend leukemia virus (FLV) inoculation in F1 mice and differentiation of FLV-induced leukemia.
    Kitagawa M; Matsubara O; Kasuga T
    Histol Histopathol; 1986 Oct; 1(4):335-40. PubMed ID: 2980128
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Nonspecific activation of macrophages for antitumor immunity.
    Strauss RR; Mills L; Patel N
    Ann N Y Acad Sci; 1976; 276():520-8. PubMed ID: 1071977
    [No Abstract]   [Full Text] [Related]  

  • 75. Circulation of lymphoid cells in mice infected with Friend leukemia virus.
    Bainbridge DR; Bendinelli M
    J Natl Cancer Inst; 1972 Sep; 49(3):773-81. PubMed ID: 4539617
    [No Abstract]   [Full Text] [Related]  

  • 76. [The effect of antilymphocyte and antimacrophage serum on the Friend mouse leukemia. The production of glomerulonephritis (author's transl)].
    Dallenbach FD; Stichs HP; Müller B; Gerber H
    Verh Dtsch Ges Pathol; 1971; 55():294-8. PubMed ID: 4130724
    [No Abstract]   [Full Text] [Related]  

  • 77. Suppression of established Friend virus leukemia by statolon. 3. Development of FV-leukemogenic and FV-immunogenic activities in bloods, spleens, and lymph nodes.
    Wheelock EF; Caroline NL; Moore RD
    J Natl Cancer Inst; 1971 Apr; 46(4):797-802. PubMed ID: 5103314
    [No Abstract]   [Full Text] [Related]  

  • 78. Cellular and serum involvement in protection against Friend leukemia virus.
    Schuller GB; Morahan PS
    Cancer Res; 1977 Nov; 37(11):4064-9. PubMed ID: 908040
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Strain difference in immune response of the rat to NRK cells infected with spleen focus-forming virus of the Friend leukaemia virus complex.
    Kai K; Yoshida M; Odaka T
    J Gen Virol; 1983 Oct; 64 (Pt 10)():2169-76. PubMed ID: 6413646
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Resistance against Friend leukemia virus-induced leukemogenesis in DNA-dependent protein kinase (DNA-PK)-deficient scid mice associated with defective viral integration at the Spi-1 and Fli-1 site.
    Hasegawa M; Yamaguchi S; Aizawa S; Ikeda H; Tatsumi K; Noda Y; Hirokawa K; Kitagawa M
    Leuk Res; 2005 Aug; 29(8):933-42. PubMed ID: 15978944
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.